Skip to main content

"Two New Parkinson's Drugs Approaching Market" (FallWinter 2018)

Two drugs to treat "off" times in Parkinson's disease (PD) could be the first MJFF-funded therapies to come to market if approved by the FDA. Also, read about progress for Fox Insight (the Foundation's online clinical study), former Pennsylvania Governer Ed Rendell's life with PD, notable advances in dementia research and trusted fundraising tips.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.